Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
129
datasets available to search
ShareScore release 0.9.0
Dataset results
129 results for “electronic cigarettes”
Data from: Experts’ consensus on use of electronic cigarettes: a Delphi survey from Switzerland
Open the record for dataset details and reuse information.
Saliva and Lung Microbiome Associations With Electronic Cigarette Use and Smoking
GEO Series GSE180785. human lung metagenome; human saliva metagenome. 54 samples. Type: Expression profiling by high throughput sequencing.
Frontal Cortex Transcriptome Analysis of Mice Exposed to Electronic Cigarettes During Early Life Stages
GEO Series GSE75858. Mus musculus. 33 samples. Type: Expression profiling by high throughput sequencing.
Electronic cigarettes
GEO Series GSE118431. Homo sapiens. 8 samples. Type: Expression profiling by high throughput sequencing.
A Pilot Study Of Immunological and Microbiome Profiling Reveals Distinct Inflammatory Profiles For Smokers and Electronic Cigarette Users [re-analysis]
GEO Series GSE227547. human lung metagenome. 28 samples. Type: Expression profiling by high throughput sequencing.
[DATABASE] Comparing the Effectiveness, Tolerability, and Acceptability of Heated Tobacco Products and Refillable Electronic Cigarettes for Cigarette Substitution (CEASEFIRE): Randomized Controlled Trial
<p><strong>Background: </strong>People who smoke and who face challenges trying to quit or wish to continue to smoke may benefit by switching from traditional cigarettes to noncombustible nicotine delivery alternatives, such as heated tobacco products (HTPs) and electronic cigarettes (ECs). HTPs and ECs are being increasingly used to quit smoking, but there are limited data about their effectiveness.</p> <p><strong>Objective: </strong>We conducted the first randomized controlled trial comparing quit rates between HTPs and ECs among people who smoke and do not intend to quit.</p> <p><strong>Methods: </strong>We conducted a 12-week randomized noninferiority switching trial to compare effectiveness, tolerability, and product satisfaction between HTPs (IQOS 2.4 Plus) and refillable ECs (JustFog Q16) among people who do not intend to quit. The cessation intervention included motivational counseling. The primary endpoint of the study was the carbon monoxide-confirmed continuous abstinence rate from week 4 to week 12 (CAR weeks 4-12). The secondary endpoints included the continuous self-reported ≥50% reduction in cigarette consumption rate (continuous reduction rate) from week 4 to week 12 (CRR weeks 4-12) and 7-day point prevalence of smoking abstinence.</p> <p><strong>Results: </strong>A total of 211 participants completed the study. High quit rates (CAR weeks 4-12) of 39.1% (43/110) and 30.8% (33/107) were observed for IQOS-HTP and JustFog-EC, respectively. The between-group difference for the CAR weeks 4-12 was not significant (P=.20). The CRR weeks 4-12 values for IQOS-HTP and JustFog-EC were 46.4% (51/110) and 39.3% (42/107), respectively, and the between-group difference was not significant (P=.24). At week 12, the 7-day point prevalence of smoking abstinence values for IQOS-HTP and JustFog-EC were 54.5% (60/110) and 41.1% (44/107), respectively. The most frequent adverse events were cough and reduced physical fitness. Both study products elicited a moderately pleasant user experience, and the between-group difference was not significant. A clinically relevant improvement in exercise tolerance was observed after switching to the combustion-free products under investigation. Risk perception for conventional cigarettes was consistently higher than that for the combustion-free study products under investigation.</p> <p><strong>Conclusions: </strong>Switching to HTPs elicited a marked reduction in cigarette consumption among people who smoke and do not intend to quit, which was comparable to refillable ECs. User experience and risk perception were similar between the HTPs and ECs under investigation. HTPs may be a useful addition to the arsenal of reduced-risk alternatives for tobacco cigarettes and may contribute to smoking cessation. However, longer follow-up studies are required to confirm significant and prolonged abstinence from smoking and to determine whether our results can be generalized outside smoking cessation services offering high levels of support.</p>
CSD170302: Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes
ClinicalTrials.gov study NCT03233997. IPD Sharing: NO. Countries: 1. Publications: 0.
Sensorimotor Replacement With Electronic and De-nicotinised Cigarettes
ClinicalTrials.gov study NCT01414998. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effects of Electronic Cigarette and Traditional Cigarette
ClinicalTrials.gov study NCT07131891. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Environmental Emissions From Electronic Cigarettes and Tobacco-Burning Cigarettes
ClinicalTrials.gov study NCT02185898. IPD Sharing: NO. Countries: 1. Publications: 0.
The Cardiovascular Impacts of Electronic Cigarettes in Comparison to the Use of Nicotine Replacement Patches
ClinicalTrials.gov study NCT03358953. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Nicotine Influence on the Retina Following the Use of Electronic Cigarette
ClinicalTrials.gov study NCT05801419. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of the Immediate Cardiovascular Effects of Electronic Cigarette in Subjects With Cardiovascular Disease
ClinicalTrials.gov study NCT02777515. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CSD170501: Study to Assess Biomarkers of Tobacco Exposure in Smokers During In-Clinic Confinement Switch to an Electronic Cigarette
ClinicalTrials.gov study NCT03170674. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of an Electronic Nicotine Delivery Device (E-Cigarette) Without Nicotine Cartridges
ClinicalTrials.gov study NCT01194583. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Psychometric Properties of the Chinese Version of Penn State [Electronic] Cigarette Dependence Index
ClinicalTrials.gov study NCT05477888. IPD Sharing: YES. Countries: 1. Publications: 0.
The Effect of Electronic Cigarette (ECIG) Liquid Vehicles on ECIG Acute Effects
ClinicalTrials.gov study NCT02500615. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine
ClinicalTrials.gov study NCT07202039. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
The Effect of Electronic Cigarette Use on Smoking Behaviors Among Smokers Receiving Outpatient Psychiatric Treatment
ClinicalTrials.gov study NCT04014322. IPD Sharing: NO. Countries: 1. Publications: 0.
A Structured Protocol to Evaluate Efficacy and Safety of a Popular Electronic Nicotine Delivery Device (E-Cigarette) Efficacy and Safety of a Popular Electronic Nicotine Delivery Device (E-Cigarette)
ClinicalTrials.gov study NCT01188239. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.